HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Journal articles

Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients

Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-02143630
Contributor : Ghislain Bidaut Connect in order to contact the contributor
Submitted on : Wednesday, May 29, 2019 - 2:51:15 PM
Last modification on : Tuesday, April 12, 2022 - 4:12:13 PM

Links full text

Identifiers

Collections

Citation

Norbert Vey, Marie Anne Hospital, Aude Collignon, Yves Collette, Daniel Birnbaum, et al.. Cegal Protocol : Evaluation of the Feasibility of a Chemogenomic Approach to Identify Personalized Therapy for Relapse or Refractory AML Patients. Blood, American Society of Hematology, 2018, 132 (1), ⟨10.1182/blood-2018-99-119263⟩. ⟨hal-02143630⟩

Share

Metrics

Record views

24